Looking At Pfizer's Recent Unusual Options Activity
Portfolio Pulse from Benzinga Insights
A significant bearish move has been observed in Pfizer's (NYSE:PFE) recent unusual options activity. Analysis revealed 70% of traders showed bearish tendencies, with 7 puts valued at $8,504,440 and 3 calls valued at $80,240. Major market movers are focusing on a price band between $20.0 and $50.0 for Pfizer. Trading volume stands at 13,151,033, with PFE's price down -2.0%, positioned at $30.62. Analysts from Barclays, UBS, Citigroup, JP Morgan, and Wells Fargo maintain neutral to equal-weight ratings on Pfizer with target prices around $34-$35.
November 08, 2023 | 7:02 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Pfizer's stock has seen a significant bearish move in its options activity. The majority of traders are bearish, and the stock's price is down -2.0%. Analysts maintain neutral to equal-weight ratings with target prices around $34-$35.
The bearish move in Pfizer's options activity, coupled with the stock's price decrease, indicates a potential short-term negative impact on the stock. The neutral to equal-weight ratings from analysts further support this view.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100